Entero Therapeutics Inc (ENTO)
0.4533
+0.04
(+9.23%)
USD |
NASDAQ |
Nov 22, 16:00
0.4433
-0.01
(-2.21%)
After-Hours: 20:00
Entero Therapeutics Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.98% |
| May 31, 2023 | 99.97% |
| April 30, 2023 | 99.97% |
| March 31, 2023 | 99.97% |
| February 28, 2023 | 99.96% |
| January 31, 2023 | 99.96% |
| December 31, 2022 | 99.96% |
| November 30, 2022 | 99.94% |
| October 31, 2022 | 99.91% |
| Date | Value |
|---|---|
| September 30, 2022 | 99.90% |
| August 31, 2022 | 99.79% |
| July 31, 2022 | 99.70% |
| June 30, 2022 | 99.59% |
| May 31, 2022 | 99.34% |
| April 30, 2022 | 98.72% |
| March 31, 2022 | 97.84% |
| February 28, 2022 | 97.56% |
| January 31, 2022 | 97.53% |
| December 31, 2021 | 97.29% |
| November 30, 2021 | 96.27% |
| October 31, 2021 | 95.16% |
| September 30, 2021 | 94.87% |
| August 31, 2021 | 91.79% |
| July 31, 2021 | 91.79% |
| June 30, 2021 | 91.79% |
| May 31, 2021 | 91.79% |
| April 30, 2021 | 91.79% |
| March 31, 2021 | 91.79% |
| February 28, 2021 | 91.79% |
| January 31, 2021 | 91.79% |
| December 31, 2020 | 91.79% |
| November 30, 2020 | 91.79% |
| October 31, 2020 | 91.79% |
| September 30, 2020 | 91.79% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
91.79%
Minimum
Nov 2019
100.00%
Maximum
Aug 2024
96.54%
Average
99.03%
Median
Max Drawdown (5Y) Benchmarks
| Pulmatrix Inc | 99.40% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -106.29 |
| Beta (5Y) | 1.221 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 111.5% |
| Historical Sharpe Ratio (5Y) | -0.812 |
| Historical Sortino (5Y) | -1.527 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 55.67% |